Parving H H, Hommel E
Hvidore Hospital, Klampenborg, Denmark.
BMJ. 1989 Jul 22;299(6693):230-3. doi: 10.1136/bmj.299.6693.230.
To assess the effect of long term antihypertensive treatment on prognosis in diabetic nephropathy.
Prospective study of all insulin dependent diabetic patients aged under 50 with onset of diabetes before the age of 31 who developed diabetic nephropathy between 1974 and 1978 at Steno Memorial Hospital.
Outpatient diabetic clinic in tertiary referral centre.
Forty five patients (20 women) with a mean age of 30 (SD 7) years and a mean duration of diabetes of 18 (7) years at onset of persistent proteinuria were followed until death or for at least 10 years.
Antihypertensive treatment was started a median of three (0-13) years after onset of nephropathy. Four patients (9%) received no treatment, and 9 (20%), 13 (29%), and 19 (42%) were treated with one, two, or three drugs, respectively. The median follow up was 12 (4-15) years.
Arterial blood pressure and death.
Mean blood pressure at start of antihypertensive treatment was 148/95 (15/50) mm Hg. Systolic blood pressure remained almost unchanged (slope -0.01 (95% confidence interval -0.39 to 0.37) mm Hg a year) while diastolic blood pressure decreased significantly (0.87 (0.65 to 1.10) mm Hg a year) during antihypertensive treatment. The cumulative death rate was 18% (8 to 32%) 10 years after onset of nephropathy, in contrast to previous reports of 50% to 77% 10 years after onset of nephropathy. As in previous studies, uraemia was the main cause of death (9 patients; 64%).
The prognosis of diabetic nephropathy has improved during the past decade largely because of effective antihypertensive treatment.
评估长期抗高血压治疗对糖尿病肾病预后的影响。
对1974年至1978年在斯滕诺纪念医院发生糖尿病肾病的、年龄在50岁以下且31岁之前患糖尿病的所有胰岛素依赖型糖尿病患者进行前瞻性研究。
三级转诊中心的门诊糖尿病诊所。
45例患者(20名女性),持续性蛋白尿发作时平均年龄为30(标准差7)岁,糖尿病平均病程为18(7)年,随访至死亡或至少10年。
肾病发作中位数3(0 - 13)年后开始抗高血压治疗。4例患者(9%)未接受治疗,9例(20%)、13例(29%)和19例(42%)分别接受一种、两种或三种药物治疗。中位随访时间为12(4 - 15)年。
动脉血压和死亡情况。
开始抗高血压治疗时的平均血压为148/95(15/50)mmHg。在抗高血压治疗期间,收缩压几乎保持不变(斜率为每年 -0.01(95%置信区间 -0.39至0.37)mmHg),而舒张压显著下降(每年0.87(0.65至1.10)mmHg)。肾病发作10年后的累积死亡率为18%(8%至32%),与之前报道的肾病发作10年后50%至77%的死亡率形成对比。与之前的研究一样,尿毒症是主要死因(9例患者;64%)。
在过去十年中,糖尿病肾病的预后有了改善,这主要归功于有效的抗高血压治疗。